NEW YORK (TheStreet) -- CHANGE IN RATINGS

Autodesk

(ADSK) - Get Report

was upgraded to buy, Jefferies said. $45 price target. Company is leveraged to a better commercial real estate cycle, Jefferies said.

Alcatel-Lucent

(ALU)

was upgraded from underperform to market perform, Bernstein Research said. New CEO can help turn the business around, Bernstein Research said.

Astex Pharmaceuticals

(ASTX)

was upgraded to buy at TheStreet Ratings.

Einstein Noah Restaurant

(BAGL)

was downgraded to hold at TheStreet Ratings.

Duke Energy

(DUK) - Get Report

was downgraded from buy to hold, Deutsche Bank said. Valuation call, based on a $69 price target, Deutsche Bank said.

Fulton Financial

(FULT) - Get Report

was downgraded from buy to neutral, Sterne Agee said. Valuation call.

Intuitive Surgical

(ISRG) - Get Report

was upgraded from hold to buy, Cantor Fitzgerald said. $575 price target. Stock has over-reacted to news of the FDA probe, Cantor Fitzgerald said.

Micros

(MCRS)

was downgraded from buy to hold, Jefferies said. $43 price target. Company will likely be hurt by lower hardware pricing, Jefferies said.

Norwegian Cruise

(NCLH) - Get Report

was initiated with a hold rating, Deutsche Bank said. $34 price target. Valuation call, as the stock is up 63% since its IPO, Deutsche Bank said.

Priceline.com

(PCLN)

was upgraded from neutral to buy, Lazard Capital Markets said. $859 price target. Competition fears have been overstated, Lazard Capital Markets said.

Webster Financial

(WBS) - Get Report

was upgraded from neutral to buy, Sterne Agee said. $25 price target. Company can deliver steady growth over the next two years, Sterne Agee said.

STOCK COMMENTS/EPS CHANGES

Chicago Bridge & Iron

(CBI)

numbers now seen reaching $58, according to Credit Suisse. Company is seeing better bookings, Credit Suisse said. Neutral rating.

Salesforce.com

(CRM) - Get Report

numbers now seen reaching $205, according to Canaccord Genuity. Company has strong business momentum, Canaccord Genuity said. Buy rating.

Viropharma

(VPHM)

was placed on the Priority Stock list, according to Wells Fargo. Valuation call, as the stock is not factoring in the company's strong fundamentals, Wells Fargo said.

>To submit a news tip, email:

tips@thestreet.com

.

READERS ALSO LIKE:

>>Kass: The Buck Stops Here

>>Lay Off Groupon's Andrew Mason, He Was Already Fired

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.